Europlasma S.A. buy krebskrebs
Start price
25.01.21
/
50%
€18,400
Target price
25.01.22
€100,000
Performance (%)
-94.46%
End price
26.01.22
€1,020.0
Summary
This prediction ended on 26.01.22 with a price of €1,020.0. The BUY prediction by krebskrebs for Europlasma S.A. performed very badly with a performance of -94.46%. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Europlasma S.A. | 0.000% | 0.000% | -99.864% | -100.000% |
iShares Core DAX® | -0.922% | -1.993% | 13.399% | 16.075% |
iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% | 46.938% |
iShares Nikkei 225® | 2.224% | -5.187% | 20.497% | 4.643% |
iShares S&P 500 | -0.026% | -0.918% | 30.410% | 42.418% |
Comments by krebskrebs for this prediction
In the thread Europlasma S.A. diskutieren
Buy mit Kursziel 10,0
In the thread Trading Europlasma S.A.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten